Armistice Capital, LLC 13D and 13G filings for Unicycive Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 3:18 pm Unchanged |
2023-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY |
Armistice Capital, LLC | 976,000 2.730% |
0 (Unchanged) |
Filing |
| 2023-02-14 1:41 pm Purchase |
2022-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY |
Armistice Capital, LLC | 976,000 6.080% |
176,000 (+22.00%) |
Filing |
| 2022-02-14 9:37 pm Purchase |
2021-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY |
Armistice Capital, LLC | 800,000 5.100% |
800,000 (New Position) |
Filing |